Basic Temovate Information

• INN (International Nonproprietary Name): Paracetamol (example; known as acetaminophen in US/Canada).
• Brand Names Available In United Kingdom: Panadol® is listed for the UK in the provided dataset; specific Temovate brand listings are not specified in the raw data.
• ATC Code: N02BE01.
• Forms & Dosages: Tablets 325mg/500mg/1000mg, syrups 120mg/5ml and 160mg/5ml, suppositories 125mg–500mg, effervescent 500mg/1000mg, and IV solution 10mg/ml — the raw data lists these forms for the example product.
• Manufacturers In United Kingdom: GSK (Panadol brands) is listed; other local manufacturers for temovate are not specified in the raw data.
• Registration Status In United Kingdom: Approved by MHRA is recorded for the example product; specific registration details for temovate are not specified in the raw data.
• OTC / Rx Classification: Generally OTC for the example product forms; prescription-only status is noted for special forms — temovate clobetasol propionate 0.05% is, however, a Prescription Only Medicine in UK practice (see article text).

Important Instructions, Warnings And Daily-Life Integration For UK Patients

Is Temovate safe for me and how should I use it at home?

• Temovate (clobetasol propionate 0.05%) is a very high‑potency topical steroid and is Prescription Only Medicine (POM) in the UK; use only as directed by your GP or dermatologist.
• Short‑term use is the norm: follow the prescriber’s duration, often up to two weeks, and avoid repeat courses without clinical review.
• Prolonged or large‑area use risks skin thinning, stretch marks and hormonal (HPA axis) effects.
• Apply a thin film to clean, dry skin and allow the product to absorb before dressing — typically 10–20 minutes.
• Avoid strong sun exposure on treated skin and do not occlude the area unless explicitly instructed by your clinician.
• Wash hands after use unless treating the hands; if treating hands, wash for hygiene after the recommended absorption time.
• If pregnant, breastfeeding, a child, or taking multiple medicines, mention this to the prescriber before starting treatment.
• Report side effects via the Yellow Card scheme and contact your clinician if you notice severe local reactions or systemic symptoms.

Everyday Use & Best Practices

Morning Vs Evening Dosing

How should I fit Temovate into my daily routine?

• Temovate is usually applied once or twice daily depending on your prescriber’s instruction.
• For most adults a single evening application is convenient and helps observe skin response overnight.
• If twice daily is advised, aim for morning and evening roughly 12 hours apart.
• Apply after your usual washing routine when the skin is dry to improve absorption.
• When treating hands or areas that contact clothing, allow 10–20 minutes to absorb to reduce transfer to garments or bedding.

Taking With Or Without Meals (UK Diet Habits)

Do I need to time Temovate with food or drinks?

• There is no need to time topical steroid use around meals; Temovate and clobetasol dosing do not interact with food.
• If you plan to eat a meal that may rub against treated areas (for example, collar areas), apply after dressing or ensure absorption time before contact.
• If you use emollients, apply the emollient first, allow it to absorb, then apply Temovate unless your clinician instructs otherwise.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Which patients need special caution with Temovate?

• Do not use Temovate on infected skin (bacterial, fungal or viral) unless the infection has been appropriately treated.
• Avoid application to the face, eyelids, groin and armpits unless directed by a specialist because of thin skin and higher risk of side effects.
• Children, pregnant or breastfeeding women, and those with widespread skin disease require specialist review due to increased systemic absorption risk and possible HPA axis suppression.
• Patients on multiple topical or systemic steroids should be reviewed for cumulative exposure and monitoring needs.

Activities To Limit (Driving, Work Safety)

Will Temovate affect my day-to-day activities?

• Topical Temovate does not usually impair driving or machine use.
• If you experience dizziness or systemic steroid effects, stop the activity and contact your clinician.
• Avoid heavy manual tasks that rub treated skin until the product has fully absorbed.
• Delay swimming or contact sport until absorption time has passed to prevent transfer to others or loss of dose.
• If you work with open food and treat your hands, inform occupational health for safe working guidance.

Dosage & Adjustments

General Regimen (NHS Guidance)

How much should I use and how do I measure it?

• Apply a thin film of Temovate once or twice daily to affected areas as directed by the prescriber.
• Use fingertip units (FTU) to estimate dose — one FTU (from fingertip to first crease) covers about two adult hand‑palms.
• Typical adult treatment durations are short, often a maximum of two weeks continuous use for most indications.
• Scalp or very stubborn plaques may require specialist management and can be limited to two to four weeks under supervision.

Special Cases (Elderly, Comorbidities)

Do older adults or people with other illnesses need different care?

• In elderly patients reduce exposure by using the minimum effective area and duration because fragile skin is more prone to atrophy.
• People with diabetes, severe liver disease or widespread skin disease may need monitoring for systemic absorption, including clinical review or morning cortisol tests.
• Children need specialist dosing and close monitoring and generally avoid treatment over large surface areas.
• If on systemic steroids or potent topical agents, prescribers consider cumulative steroid load when setting duration and follow‑up.

User Testimonials

Positive Reports From UK Patients

What do patients say about Temovate in real life?

• Many UK patients report rapid improvement in thick psoriasis plaques and severe eczema flares within days of starting a very‑potent steroid like Temovate.
• Positive feedback commonly mentions reduced itch, less redness and scale, and restored sleep and comfort within a short time.
• Patients who received clear instructions and a written treatment plan felt more confident about using a potent steroid wisely.

Common Challenges (Patient.info, NHS Forums)

What problems do people commonly face?

• Common challenges include rebound flares after stopping, local skin thinning after repeated courses, and difficulty stopping long‑term use without relapse.
• Online threads on NHS forums and Patient.info highlight confusion about duration and concerns over potency.
• Clinicians recommend a written stop/review date and a follow‑up plan to reduce anxiety and avoid inappropriate long‑term use.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Where can I get Temovate in the UK?

• Temovate is a prescription‑only medicine and is obtained via a GP or dermatology prescription and dispensed at community pharmacies such as Boots, LloydsPharmacy and independent chemists.
• MHRA‑regulated online pharmacies (for example, Pharmacy2U or Superdrug Online Pharmacy) may dispense after a valid prescription and with pharmacist verification.
• Always check packaging and patient information leaflets to confirm brand (Temovate, Dermovate or generic clobetasol) and formulation.

Price Comparison (NHS Prescription Charge Vs Private)

How much will it cost on the NHS or privately?

Note: NHS prescription charge in England is approximately £9.65 per item as of 2024 unless exempt; Scotland, Wales and Northern Ireland currently offer free NHS prescriptions.

In our online pharmacy, temovate is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

What’s Inside & How It Works

Ingredients Overview

What is the active ingredient in Temovate?

• Temovate contains clobetasol propionate 0.05% as the active ingredient, a super‑potent (group IV) topical corticosteroid.
• Formulations include cream, ointment and scalp solution, with excipients varying by base such as aqueous cream or paraffin‑rich ointment.
• If you have sensitivity to excipients like fragrances or parabens, check the patient information leaflet before use.

Mechanism Basics Explained Simply

How does clobetasol relieve my skin symptoms?

• Clobetasol binds glucocorticoid receptors in skin cells and reduces production of inflammatory mediators.
• It suppresses local immune responses and causes vasoconstriction to reduce redness, swelling and itch.
• In psoriasis it also slows abnormal skin cell proliferation, which helps clear thick plaques.
• Systemic absorption is minimal with short, limited application but increases with large areas, occlusion, broken skin or prolonged use.

Main Indications

Approved Uses (MHRA Listing)

Which conditions is Temovate licensed to treat?

Because of its potency and side‑effect profile, a step‑down to a less potent steroid or non‑steroidal therapy is commonly advised once the condition is controlled.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

Will food or drink affect Temovate?

• Topical clobetasol has negligible direct food interactions; you do not need to change alcohol, tea or coffee intake when applying Temovate.
• Interaction concerns arise only if substantial systemic absorption occurs, which is uncommon with short, localised use.

Drug Conflicts (MHRA Yellow Card Reports)

Are there medicines or vaccines I should tell my clinician about?

• Tell your prescriber if you are on systemic immunosuppressants or oral steroids, as combined immunosuppression may increase infection risk.
• Live vaccines may be affected by systemic steroid exposure; inform your clinician before vaccination.
• Avoid concurrent use of other potent topical steroids on the same site and discuss combining Temovate with topical antifungals or retinoids first.
• Report any suspected adverse reaction, especially systemic effects or severe local reactions, via the MHRA Yellow Card scheme.

Latest Evidence & Insights

What have recent UK and EU studies said about potent topical steroids?

• Guidance from 2022–2025 emphasises steroid stewardship: use the lowest effective potency for the shortest duration and set clear treatment end‑points.
• Short‑term efficacy for very‑potent steroids like clobetasol is supported for stubborn plaques, but evidence also shows measurable risks such as skin atrophy and HPA axis suppression with high cumulative exposure.
• Specialist centres recommend documented tapering plans and switching to maintenance strategies — emollients, intermittent lower‑potency steroids or non‑steroidal alternatives — to prevent rebound.
• Research into topical steroid withdrawal has increased patient awareness and underlines the need for supervised use and shared decision‑making between patient and prescriber.

Alternative Choices

What can be used instead of Temovate if it’s unsuitable?

• Moderate‑potency steroids such as betamethasone valerate 0.1% or mometasone offer lower atrophy risk but may be less effective for very thick plaques.
• Mild OTC steroids like hydrocortisone 1% are suitable for face and children where appropriate.
• Topical calcineurin inhibitors (tacrolimus, pimecrolimus) are steroid‑sparing, suitable for face and flexures and avoid skin thinning, though they can sting and are prescription only.
• Emollients and keratolytics such as salicylic acid are useful supportive therapies and part of long‑term maintenance.
• Discuss pros and cons with your GP or dermatologist and use shared decision‑making to balance potency against safety, cost and formulary availability.

Regulation Snapshot

How is Temovate regulated in the UK?

• Clobetasol propionate 0.05% brands such as Temovate or Dermovate are Prescription Only Medicines in the UK and must be supplied with a valid prescription.
• MHRA licences cover product safety and leaflet content, and adverse events should be reported via the Yellow Card scheme.
• GPs prescribe following local formularies and shared‑care agreements while dermatology clinics may issue time‑limited or specialist repeat prescriptions.
• NHS guidance encourages documented indication, duration and follow‑up to limit inappropriate long‑term use and online pharmacies must be GPhC‑registered and verify prescriptions.

FAQ

• Can I use Temovate on my face? — Generally no; facial skin is thinner and more prone to atrophy, so only use if a specialist advises for short periods with close review.
• How long until I see improvement? — Many patients notice reduced redness and itch within days; thick plaques may take one to two weeks to respond.
• What if I miss a dose? — Apply as soon as you remember and do not double up the next application.
• How should I stop treatment? — Stop after the prescribed course; for longer courses follow a tapering plan provided by your clinician to reduce rebound risk.
• Where to get more help? — Contact NHS 111 for urgent concerns and report suspected adverse reactions to the MHRA Yellow Card scheme.

Guidelines For Proper Use

What will the pharmacist tell me when dispensing Temovate?

• Confirm indication and explain how to measure an FTU so you understand the thin‑film rule.
• Advise duration (usually ≤2 weeks) and request confirmation of pregnancy, breastfeeding, children in household and other medicines being used.
• Warn about signs of local infection, skin thinning or systemic corticosteroid effects and explain Yellow Card reporting.
• Recommend a written stop/review date on the prescription and suggest a follow‑up appointment if symptoms worsen or do not improve.
• Advise safe disposal: return unused tubes to a pharmacy; do not flush or place in household waste.

Delivery Across United Kingdom